🇺🇸 Buprenorphine patch and sublingual tablets in United States

Buprenorphine patch and sublingual tablets (Buprenorphine patch and sublingual tablets) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Buprenorphine patch and sublingual tablets in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Buprenorphine patch and sublingual tablets approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Buprenorphine patch and sublingual tablets in United States?

Psychiatric University Hospital, Zurich is the originator. The local marketing authorisation holder may differ — check the official source linked above.